FIP Foundation and ECPG Innovation Research Grant
Applications for the 2024 award are yet to be open
The Foundation, together with the FIP ECPG, awards a grant of EUR 1,000 for the implementation of a project by an ECPG member. The grant serves to encourage
innovation in pharmacy by an early-career pharmacist or pharmaceutical scientist who has limited resources for their own research. Projects can stem from any field of pharmacy (practice, science or education) but must focus on innovation that improves the practice of pharmacy or the advancement of pharmaceutical science with direct clinical application.
Pending the acceptance of a project report, the awardee may, in addition, be granted complementary registration, a return APEX airfare and hotel accommodation to attend the 82nd FIP World Congress of Pharmacy and Pharmaceutical Sciences in Cape Town, South Africa.
Judging – Applications are evaluated based on five criteria: significance & relevance, creativity & innovation, scientific accuracy, feasibility, and clarity of communication.
Grant conditions – The grant recipient is expected to submit a project report to the FIP Foundation for Education and Research and to present on the winning project at the 82nd FIP congress. He or she will also be obliged to submit interim reports and updates as required by the FIP ECPG or the FIP Foundation.
How to apply: Please use this application form. Applications for the 2024 award are yet to be open
Here are some Tips for Success and Pointers for Innovation Research Grant Application that might help you in your application.
Recent professional innovation awardees include:
2022: Brian Cicali, USA
Brian Cicalu will conduct a project titled “Model-informed Evidence Approach for Pediatric and Neonate Dosing of Tramadol. Results will be reported at the 2023 FIP World Congress in September 2023.
|2020: Dallas Smith, Malawi
Dallas Smith is a recent PharmD graduate with a passion for equitable pharmaceutical interventions. He is a clinical pharmacy and pharmacognosy lecturer at the College of Medicine, University of Malawi. His project explores the role of an ambulatory care pharmacist in an outpatient hypertension clinic in urban Malawi. Through capacity building in this local pharmacist, this study will evaluate blood pressure control and medication adherence through medication therapy management (MTM) services. Dallas hopes the outcomes of this data will encourage public and private entities in Malawi to employ ambulatory pharmacists and expand the role of the pharmacy profession.
|2019: Shepard Nqobile Mhlaba, Zimbabwe
Shepard Mhlaba is a Young Pharmacist from Zimbabwe, with keen interest in Global Health. He has served the International Pharmaceutical Federation Young Pharmacists Group as a Subcommittee Member and is currently serving FIP as Global Lead for Pharmaceutical Workforce Development Hub. His research on integrating supply chain management practices in community pharmacies and information technology was inspired by the disheartening poor supply chain practices affecting developing countries. This has resulted in significant expired medicines. His research aims to improve access to medicines and also to give a step towards universal health coverage by ensuring effective use of available scarce resources.
|2018: Jack Collins, Australia
Jack is a PhD candidate at The University of Sydney and a practising community pharmacist in Australia. Jack’s area of research is the role of the community pharmacy in consumer self-care. His project explores whether implicit (unconscious) racial bias is present in practising community pharmacists through the use of simulated patients. Through this pilot research, Jack aims to determine to what extent implicit racial bias is present and then use these findings to go on to explore other potential biases and eventually develop interventions to address this bias to improve the uniformity of patient care regardless of patient demography.
|2017: Chelsea Thorn, Australia
Chelsea is a PhD candidate from the University of South Australia and a registered pharmacist in Australia. Her project focuses on identifying new solutions to treat highly tolerant bacterial infections relating to biofilms. The direction is to deliver antibiotics with biofilm-dispersing enzymes through a nano-carrier delivery formulation.
With the innovative formulation, Chelsea is attempting to improve the efficacy of infection treatment, especially for the drug-tolerant infections.
|2016: Ekpenyong Aniekan, Nigeria
Ekpenyong’s project was about developing adequate human resources for pharmacy in developing countries. It was piloted in Nigeria and involved using data to make a five-year trend assessment and in-depth analysis of the pharmacy workforceacross 36 states to inform workforce planning and policy development.
|2015 Arcelio Benetoli, Australia
Arcelio was a PhD candidate in Pharmacy Practice at the University of Sydney, and before that received his MSc in Pharmaceutical Sciences from the State University of Maringa, Brazil. His research focused on how consumers use social media for health purposes. The research comprised an observational study which identified chronic disease public Facebook groups whose content was quantitatively and qualitatively analysed and consumer focus groups. Understanding how consumers use social media will assist health care providers in guiding consumers in their social media health journey; and importantly, help design innovative ways to deliver care via social media, accessing people who may not visit health care professionals regularly.
|2014 Vivian Tong, Australia
Vivian was a PhD Candidate at the University of Sydney. Her PhD focus was on optimising written medicine information to support safe and appropriate consumer use of over-the-counter medicines. The research focus for the grant was to develop and test alternative standardised over-the-counter medicine label formats. The new labels were informed by consumer opinions and good information design. Vivian found that the new labels performed well when user tested and consumers were able to find and understand key points of information about their medicine.